IPO registrations (S-1, F-1) · Registrants

GENENCOR INTERNATIONAL INC

SEC CIK
1113099 · filings on EDGAR ↗
Registration
Form S-1, first filed 2000-05-05, last 2000-07-27; 1 initial registration, 5 amendments
Outcome
Final prospectus filed 2000-07-28
Industry (SIC)
In Vitro & In Vivo Diagnostic Substances 2835
Incorporated in
DE
Business address
925 PAGE MILL ROAD, Palo Alto, CA 94304
EIN
16-1362385
EDGAR entity type
operating

Offering terms

Proposed price range
$16.00–$18.00 per share (S-1/A filed 2000-07-27)
Final price
$18.00 per share, within the range (424B1 filed 2000-07-28, an initial public offering)
Shares sold
7,000,000
Gross proceeds
$126,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol GCOR
Lead underwriters
Merrill Lynch; Credit Suisse (1,340,000 shares); Citigroup (1,340,000 shares); J.P. Morgan (1,340,000 shares)
Syndicate
Hambrecht & Quist; ING Barings LLC (300,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 7

FiledFormWhat it isName as filedEDGAR
2000-05-05S-1S-1 (registration)GENENCOR INTERNATIONAL INC0000891618-00-002552 ↗
2000-06-26S-1/AS-1/A (amendment)GENENCOR INTERNATIONAL INC0000891618-00-003543 ↗
2000-06-30S-1/AS-1/A (amendment)GENENCOR INTERNATIONAL INC0000891618-00-003688 ↗
2000-07-24S-1/AS-1/A (amendment)GENENCOR INTERNATIONAL INC0000891618-00-004041 ↗
2000-07-26S-1/AS-1/A (amendment)GENENCOR INTERNATIONAL INC0000891618-00-004083 ↗
2000-07-27S-1/AS-1/A (amendment)GENENCOR INTERNATIONAL INC0000891618-00-004094 ↗
2000-07-28424B1424B1 (final prospectus)GENENCOR INTERNATIONAL INC0000891618-00-004138 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-07-27S-1/Aregistration statement$16.00–$18.00$9.707,000,000$67,900,000Nasdaq GCOR5primary document; range, price sentence, shares headline, proceeds computed, cover names 4document ↗
2000-07-28424B1final prospectus$18.007,000,000$126,000,000Nasdaq GCOR6primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4document ↗

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationDANISCO US INC.CAState business registriesEIN (EXACT, as the state registration reports it)
NonprofitTOASTMASTERS INTERNATIONALCANonprofits (IRS Form 990)same street address and ZIP code, 925 PAGE MILL RD 94304 (FUZZY: a shared address, not proof of a shared organization)
Patent assigneeGENENCOR INTERNATIONAL, INC.CAPatents (USPTO)name and state
Trademark ownerGenencor International, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorDANISCO USA, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry In Vitro & In Vivo Diagnostic Substances, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: In Vitro & In Vivo Diagnostic Substances · Health